OWKIN is the AI startup that uses machine learning to augment medical and biology research.
Owkin deploys AI and Federated Learning technologies to augment medical research and enable scientific discoveries.
Owkin was co-founded in 2016 by Thomas Clozel and Gilles Wainrib. The company is headquartered in New York, with offices in Paris and Nantes, France.
Owkin enables researchers to use data from health care or research activities to train interpretable machine learning models. These models allow better prediction of patient prognosis and response to treatment, developing new generations of biomarkers.
Owkin has created a unique research platform, and a portfolio of AI models and solutions. Owkin Loop is the foundation of Owkin’s research platform: it connects medical researchers with high-quality datasets from leading academic research centers around the world.
Owkin is backed by GV, F-Prime Capital, Bpifrance Large Venture, Cathay Innovation, Mubadala Capital, Eight Roads and others. The company raised $18M in Series A round on June 30, 2020. This brings Owkin's total funding to $70.1M to date.